Staar Surgical sees Q1 ICL sales $65M-67M, consensus $67.01M

Staar Surgical sees Q1 ICL sales of $65M-67M, representing 11%-14% growth over $58.7M a year ago, the company stated in presentation slides. See the top stocks recommended by analysts >>

Read More on STAA:

• Staar Surgical price target lowered to $78 from $83 at Needham
• Staar Surgical reports Q4 EPS 12c, consensus 5c
• Staar Surgical downgraded to Neutral from Buy at BTIG
• Staar Surgical price target raised to $80 from $79 at Canaccord
• Staar Surgical price target raised to $79 from $76 at Canaccord